Interim guidelines for COVID-19 antibody testing : interim guidelines for COVID-19 antibody testing in clinical and public health settings

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Aug. 1, 2020 ; Data that will inform antibody testing (also referred to as serologic testing) guidance are rapidly evolving. Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SARS-CoV-2 will be updated as new information becomes available.
• Content Notes:
  Background -- Development of Antibodies and Immunity -- Current Status of Antibody Testing in the United States -- Types of Antibody Testing -- Optimizing Testing Outcomes -- Limitations -- Recommendations for Use.
• Subjects:
  • Antibodies, Viral/blood
  • Betacoronavirus
  • Clinical Laboratory Techniques
  • Coronavirus Infections/diagnosis
  • COVID-19 Testing
  • Pandemics
  • Pneumonia, Viral/diagnosis
• Document Type:
  Webpage
• Genre:
  Guideline
• Place as Subject:
  United States
• Download URL:
  https://stacks.cdc.gov/view/cdc/91381/cdc_91381_DS1.pdf
• File Type:
  [PDF - 242.48 KB]
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:310d6f6cefe4499182e68f4ae65dfd11092b2eb099d300053362dd70bc34096e